Department of Cardionephrology, University of Genoa, Azienda Ospedaliera Universitaria San Martino, Genoa, Italy.
J Hypertens. 2010 Apr;28(4):848-55. doi: 10.1097/HJH.0b013e328336ed09.
Decreased glomerular filtration rate (GFR) and microalbuminuria predict cardiovascular events and mortality in the general population and in high-risk patients. Their combined prognostic power in low-risk patients has never been reported. We assessed the prognostic role of GFR and albuminuria for cardiovascular disease and all-cause mortality in nondiabetic patients with primary hypertension.
We conducted an 11.2-year follow-up of 837 uncomplicated hypertensive patients enrolled in the Microalbuminuria: A Genoa Investigation on Complications (MAGIC) cohort between 1993 and 1997. Urinary albumin-to-creatinine ratio (ACR) and estimated GFR (eGFR) were assessed in untreated patients at baseline. Renal dysfunction was defined as the inclusion in the most unfavorable sex-specific decile of eGFR or of ACR. The primary endpoints were the occurrence of fatal and nonfatal cerebrovascular and cardiac events (CVEs), composite of nonfatal cerebrovascular and cardiac events (CVD) and all-cause death (CEP), and composite of CVD and chronic renal insufficiency (CRE).
During 9374 person-years of follow-up, the incidence rate for CVE, CRE, and all-cause mortality was 6.3, 7.8, and 3.1 /1000 person-years, respectively. Renal dysfunction was associated with increased risk for CVE [relative risk (RR) 2.13, 95% confidence interval (CI) 1.15-3.93, P = 0.011], CEP (RR 1.78, 95% CI 1.02-3.08, P = 0.027), and CRE (RR 2.47, 95% CI 1.45-4.29, P < 0.001), even after adjusting for several baseline covariates such as sex, duration and severity of blood pressure, and total cholesterol.
Renal dysfunction is a risk factor for cardiorenal events and all-cause mortality, regardless of traditional confounders, in uncomplicated patients with primary hypertension.
肾小球滤过率(GFR)下降和微量白蛋白尿可预测普通人群和高危患者的心血管事件和死亡率。它们在低危患者中的联合预后能力尚未得到报道。我们评估了肾小球滤过率和白蛋白尿对原发性高血压无并发症患者心血管疾病和全因死亡率的预后作用。
我们对 1993 年至 1997 年期间参加微白蛋白尿:热那亚并发症研究(MAGIC)队列的 837 例单纯性高血压患者进行了 11.2 年的随访。在基线时,未接受治疗的患者评估了尿白蛋白与肌酐比值(ACR)和估算的肾小球滤过率(eGFR)。肾功能障碍定义为 eGFR 或 ACR 纳入最不利的性别特定十分位数。主要终点是致命和非致命脑血管和心脏事件(CVE)、非致命脑血管和心脏事件(CVD)和全因死亡(CEP)的复合终点以及 CVD 和慢性肾功能不全(CRE)的复合终点。
在 9374 人年的随访期间,CVE、CRE 和全因死亡率的发生率分别为 6.3、7.8 和 3.1/1000 人年。肾功能障碍与 CVE 的风险增加相关[相对风险(RR)2.13,95%置信区间(CI)1.15-3.93,P = 0.011]、CEP(RR 1.78,95%CI 1.02-3.08,P = 0.027)和 CRE(RR 2.47,95%CI 1.45-4.29,P < 0.001),即使在调整了性别、血压持续时间和严重程度以及总胆固醇等几个基线协变量后也是如此。
在原发性高血压无并发症患者中,无论传统混杂因素如何,肾功能障碍都是心血管和肾脏事件及全因死亡率的危险因素。